BTIG analyst Mark Massaro raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $11.00 (from $10.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE